Novel CNS Biomarkers Summit Europe 2026

 

The Novel CNS Biomarkers Summit Europe is the only European meeting dedicated exclusively to advancing fluid, imaging, and digital biomarkers for CNS drug development.

Bringing together biomarker, translational medicine, neuroscience, and clinical development leaders, the summit focuses on accelerating the discovery, validation, and implementation of next-generation biomarkers across neurodegenerative and neurological diseases.

Why Attend?

• Join 60+ biomarker and translational medicine leaders

• Gain insights from 17+ expert speakers

• Explore biomarker strategies across 6+ CNS indications

• Participate in interactive workshops and networking opportunities

• Learn from leading organisations including Roche, UCB, Lundbeck, Servier, and more

 

More Info

---

---